The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 Jan 2008 07:01

Amphion Innovations PLC17 January 2008 Amphion Innovations plc Trading Update 17 January 2008 - Amphion Innovations plc (LSE: AMP) ('Amphion' or the'Company'), is pleased to announce that results for the 12 month period to 31December 2007 are expected to show an increase in Net Asset Value per Share of29% to $0.44 (£0.22), broadly in line with market expectations. Profit beforeTax is expected to be approximately $10.5 million, a 50% increase from theprevious year, primarily reflecting the uplift in the value of the investments. Amphion builds shareholder value in high growth companies in the medical andtechnology sectors, by using a focused, hands-on company building approach,based on decades of experience in both the US and UK. Currently there are 10Partner Companies developing proven technologies targeting substantialcommercial marketplaces, in excess of $1 billion. Each Partner Company aims toachieve a target exit value in excess of $100 million supported by Amphionmanagement team's strong track record of delivering liquidity events. During 2007, Amphion successfully helped its Partner Companies raise over $21million. Looking ahead, the Company expects to build on the substantial progress made in2007. Following a successful fundraising, WellGen is in a strong position tomeet its commercial objectives in 2008, having raised $9.5 million in October2007. Durham Scientific Crystals is also well placed following the signing of acontract with the UK Home Office in December 2007. The contract is to developits groundbreaking technology for digital x-ray imaging for use in both medicalapplications and airport security scanners to detect explosives and flammablematerial. Amphion is pleased to report that its Gulf based joint venture, MSA, has beenfully incorporated and capitalized. This will enable it to move forward with thecompany's business plan and to develop strategic partnerships for Amphion andits Partner Companies in the Gulf region. During 2007 Amphion continued to develop its two new Partner Companies, EnergyTrading International ('ETI') and DataTern Inc. ETI seeks to exploit the trendtowards automation of markets through the development of a proprietary(patented) platform for the automatic negotiation and execution of bilateral,structured trades. DataTern Inc. is being formed to develop and extract valuefrom the substantial and growing patented portfolio in Amphion's PartnerCompanies. The Company estimates that its Partner Companies have over 150individual pieces of intellectual property, double the amount at the time oflisting in August 2005. Amphion expects to announce its preliminary results for the 12 months to 31December 2007, in March 2008. Richard C.E. Morgan, Amphion's Chief Executive Officer, said: "During 2007,Amphion and our Partner Companies achieved several key milestones. We arefocused on creating shareholder value, and given the strength of our PartnerCompanies, we are very confident of being able to continue to deliver furthergrowth." For further information please contact: Amphion InnovationsCharlie Morgan:+1 (212) 210-6224 Cardew GroupTim Robertson/ Jamie Milton/Matthew Law:+44 020 7930 0777 Charles Stanley Securities, Nominated AdvisorMark Taylor/ Freddy Crossley:+44 020 7149 6000 On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 20067:01 amRNSAppointment
6th Jun 20067:01 amRNSRe Agreement
5th Jun 20063:16 pmRNSThe Shafallah Center
2nd Jun 20065:01 pmRNSDr David Evans
1st Jun 20067:00 amRNSAnnual Report and Accounts
23rd May 20067:00 amRNSDirector/PDMR Shareholding
22nd May 20061:41 pmRNSDirector/PDMR Shareholding
19th May 20065:12 pmRNSDirector Share Transaction
15th Mar 20069:25 amRNSCompletion of a Financing
8th Mar 20067:04 amRNSFinal Results
2nd Mar 20069:12 amRNSMotif BioSciences
27th Feb 20064:56 pmRNSNotice of Results
23rd Feb 20067:02 amRNSRe: WellGen Financing
3rd Jan 20067:01 amRNSAdditional Investments
5th Dec 200512:48 pmRNSDirector Shareholding
10th Oct 20057:00 amRNSAcquires a stake
21st Sep 20057:00 amRNSStake in Spin-Out Company
30th Aug 20057:00 amRNSAmphion Invests in WellGen
25th Aug 20054:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.